Sector
HealthcareOpen
₹1,696Prev. Close
₹1,692.3Turnover(Lac.)
₹4,786.45Day's High
₹1,702.5Day's Low
₹1,681.352 Week's High
₹2,318.352 Week's Low
₹1,315Book Value
₹244.6Face Value
₹2Mkt Cap (₹ Cr.)
8,754.52P/E
70.08EPS
24.09Divi. Yield
0The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 10.25 | 10.24 | 10.23 | 10.22 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,020.94 | 925.77 | 828.97 | 654.59 |
Net Worth | 1,031.19 | 936.01 | 839.2 | 664.81 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
---|---|---|---|---|
Revenue | 1,117.13 | 961.38 | 665.3 | 404.66 |
yoy growth (%) | 16.19 | 44.5 | 64.4 | |
Raw materials | -252.67 | -244.23 | -167.24 | -101.87 |
As % of sales | 22.61 | 25.4 | 25.13 | 25.17 |
Employee costs | -210.12 | -188.24 | -147.66 | -94.64 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 245.87 | 242.12 | 164.51 | 131.41 |
Depreciation | -55.88 | -43.78 | -30.84 | -12.18 |
Tax paid | -69.53 | -59.47 | -27.93 | -43.4 |
Working capital | -234.23 | 238.14 | 223.59 | |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.19 | 44.5 | 64.4 | |
Op profit growth | 8.46 | 62.95 | 44.23 | |
EBIT growth | 6.16 | 46.01 | 29.83 | |
Net profit growth | 5.24 | 63 | 27.32 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 1,331.2 | 1,207.71 | 1,148.21 | 1,228.34 | 997.99 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,331.2 | 1,207.71 | 1,148.21 | 1,228.34 | 997.99 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 15.11 | 9.12 | 15.22 | 33.52 | 12.05 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,266.5 | 162.98 | 1,23,107.82 | 177.39 | 0.12 | 658.7 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,101.5 | 78.77 | 1,02,110.83 | 333.4 | 0.39 | 2,075.3 | 607.44 |
Fortis Healthcare Ltd FORTIS | 790.7 | 465.24 | 59,709.64 | -42.23 | 0.13 | 388.47 | 120.19 |
Narayana Hrudayalaya Ltd NH | 2,073.3 | 98.14 | 42,319.04 | 159.98 | 0.22 | 919.03 | 106.95 |
Aster DM Healthcare Ltd ASTERDM | 596 | 5.25 | 30,911.1 | 61.07 | 19.88 | 573.86 | 79.8 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Sushil Kanubhai Shah
Chairperson & Whole Time Direc
Ameera Sushil Shah
Independent Director
VIVEK GAMBHIR
Independent Director
Sanjay Bhatnagar
Non-Exec & Non-Independent Dir
Hemant Sachdev
Company Sec. & Compli. Officer
KAMLESH KULKARNI
Non Executive Director
Aparna Rajadhyaksha
Independent Director
Subramanian Ranganathan
Additional Director
Purvi Sheth
Additional Director
REHAN KHAN ABBAS
250 D Udyog Bhavan,
Worli,
Maharashtra - 400030
Tel: 91-22-62582810
Website: http://www.metropolisindia.com
Email: [email protected]
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: [email protected]
Summary
Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desais Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kan...
Read More
Reports by Metropolis Healthcare Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.